JavaScript is
disabled!
Please enable to improve your experience.
THIS IS AN ADVERTISEMENT
health care
uninterrupted.
Hall Render Advisory Services
COVID-19 Resources
MENU
About Us
Diversity, Equity & Inclusion Overview
Recognition
Firm Leadership
Services
Our People
Attorneys
Consultants
Administrative Team
Offices
Anchorage Office
Dallas Office
Denver Office
Detroit Office
Indianapolis Office
Milwaukee Office
Raleigh Office
Washington, D.C. Office
Resources
Articles
Firm News
Webinars
Presentations
Podcasts
Careers
Contact
MENU
Search
About Us
Diversity, Equity & Inclusion Overview
Recognition
Firm Leadership
Services
Our People
Attorneys
Consultants
Administrative Team
Offices
[Column]
[Column]
[Column]
[Column]
Resources
Articles
Firm News
Webinars
Presentations
Podcasts
Careers
Contact
Hall Render Advisory Services
COVID-19 Resources
Resources
Publications by Melissa L. Markey
< back to bio
Remanufacturing or Servicing of Medical Devices: FDA Issues Final Guidance Providing Additional Clarification
[06/21/24]
FDA's Data Monitoring Guidance Reveals Future Expectations
[06/11/2024]
From Discretion to Regulation: What FDA’s Final Rule Means for Laboratory Developed Tests
[06/05/24]
Data Monitoring Committees in Clinical Trials: FDA Draft Guidance Released
[05/22/24]
“Patient Rights: Informed Consent and Clinical Research.” Enterprise Risk Management for Health Care Fourth Edition, AHLA/ASHRM, March 2024.
Preparing for Change: After 20 Years, HHS Proposes Update to Research Misconduct Regulations
[02/16/24]
A Whole New World for Laboratory Developed Tests – FDA Proposes End to Its Longstanding Policy of Enforcement Discretion
[11/30/23]
Biden Administration Issues Executive Order on Artificial Intelligence with Potential Big Impacts for the Health Care Sector
[11/28/23]
FDA Finalizes Its Informed Consent Guidance for IRBs, Clinical Investigators and Sponsors
[10/05/23]
Embracing Technology: FDA Releases Draft Guidance on Decentralized Clinical Trials
[09/14/23]
A Look Back at the Office of Prescription Drug Promotion Enforcement in 2022 and Lessons for 2023
[03/29/23]
OCR Issues Bulletin Regarding the Use of Web Tracking Technologies
[12/21/22]
Scrutiny Increases into the Use of Website Tracking Tools in Health Care
[08/19/22]
FDA Revises Health System Compounding Guidance, Implementing a More Practical Approach
[10/14/21]
PREP Act Eligibility Expanded for Pharmacists, Pharmacy Technicians and Interns Administering COVID-19 Therapeutics
[10/01/21]
Medicare Payment for COVID-19 Vaccines and Antibody Therapy
[12/21/20]
Important Information for COVID-19 Vaccine Providers
[12/15/20]
Overview of Legal and Practical Considerations for Employers Concerning COVID-19 Vaccination Policies
[12/10/20]
CMS Accepting Waiver Applications to Permit Hospital Care at Home
[11/30/20]
Federal Agencies Warn of Significant and Imminent Cyber Security Threat Targeting the Health Care and Public Health Sectors
[10/29/20]
Potential Vendor Breach
[07/17/20]
PREP Act Immunity for Pharmacists Ordering COVID-19 Tests: New HHS OGC Advisory Opinion Addresses Conflicting State Laws
[05/21/20]
Indiana’s House Enrolled Act No. 1004 – Two Key Developments That Will Affect Every Physician Employer in Indiana (Part II of II)
[05/18/20]
FDA Details Authorized Treatment Pathways and Collection Requirements for Administration of COVID-19 Convalescent Plasma
[04/21/20]
FEMA Restricts Export of PPE in Temporary Final Rule
[04/10/20]
Zooming into Risk During COVID-19
[04/08/20]
Health Care Providers and FEMA’s COVID-19 Public Assistance
[04/03/20]
Seeking Solutions for Scarce Resources: Options to Boost Medical Supplies and Devices to Battle COVID-19
[03/26/20]
FDA Issues Guidance on COVID-19 Disruptions to Clinical Trials
[03/19/20]
Battling the Bugs: Cybersecurity During a Pandemic
[03/19/20]
HIPAA Compliance During the COVID-19 Pandemic
[03/18/20]
USDA Hemp Producer License – Do the Opportunities Outweigh the Risks?
[01/27/20]
Apple Debuts Application for Users to Participate in Health Studies
[11/22/19]
Homeopathic Products Manufacturers Beware – FDA Steps Up Plans for New Enforcement Regime
[10/25/19]
Deficient Risk Analyses, Stolen Records and Disclosure of NFL Player’s PHI Leads to $2.15 Million Penalty
[10/25/19]
What’s in YOUR Cannabidiol Product Claim? FDA and FTC Want to Know
[10/24/19]
Failure to Provide Timely Access to Records Results in $85,000 Fine
[09/10/19]
The Practice of Medicine vs. Protecting Patient Safety: Groundbreaking Court Ruling in Support of the FDA’s Regulation of Certain Stem Cell Therapies
[06/11/19]
Consider Website and Other Technology Accessibility Obligations to Better Serve Your Community and Avoid Litigation and Loss of Federal Funding
[03/01/19]
Digital Medicine: OIG Approves Arrangement to Provide Smartphones to Patients
[02/15/19]
Important Alert: Response to Emailed Bomb Threats
[12/13/18]
Department of Homeland Security and FDA Collaborate to Address Medical Device Cybersecurity
[11/02/18]
Hurricane Florence: HHS Responds to a Public Health Emergency by Issuing HIPAA Privacy Rule Waiver and Equal Access Guidance
[09/19/18]
OIG Requests Information from Stakeholders to Expand Anti-Kickback Statute and Civil Monetary Penalty Safe Harbors
[09/14/18]
Blockchain in Health Care Explained: A Three-Part Series
[07/26/18]
Delay of “2018 Requirements” that Revise the Common Rule
[04/04/18]
SSAE 18 Replaces SSAE 16 Data Security Audit Standard – Practical Takeaways
[01/22/18]
CMS Clarifies that Texting PHI Through Secure Platforms Is Permissible – But Not Orders!
[12/29/17]
Final FDA Guidance on Interoperable Medical Devices
[09/20/17]
HHS Finalizes Major Updates to Regulations for Protection of Human Research Subjects
[01/19/17]
Privacy Shield Principles Permit Transfer of Personal Data Between United States and European Union
[10/04/16]
Your Money or Your PHI: New Guidance on Ransomware
[07/19/16]
Safe Harbor Agreement Between United States and EU Ruled Invalid
[10/06/15]
Ebola Preparedness – Important Takeaways from the October 21, 2014 Livestream Session
[10/22/14]
Ebola Preparedness – Take Steps Now to Ensure Health Care Workers and Hospitals Are Prepared to Care for Ebola Patients
[10/17/14]
Ebola Preparedness – Detect, Protect and Respond: Next Steps for Health Care Providers and In-House Counsel
[10/13/14]
Ebola Preparedness: Considerations for Clients and In-House Counsel
[10/03/14]
Attorney-Client Privilege - Healthcare Compliance Legal Issues Manual, AHLA
HIPAA Confidentiality (ed.) - Healthcare Compliance Legal Issues Manual, AHLA Attorney-Client Privilege - AHLA
HIPAA Security - Healthcare Compliance Legal Issues Manual, AHLA
Privacy Issues - The Fundamentals of Life Sciences Law: Drugs, Devices, and Biotech, AHLA
Federal Regulators Accepting Comments on Health IT Regulatory Framework
[04/10/14]
FDA, ONC and FCC Issue Long-Awaited Recommendations for Regulation of Health IT
[04/10/14]
FDASIA Report Tasks FDA with Clarifying Its Approach to Health IT
[04/10/14]
Ebola: A Public Health and Legal Perspective - ABA Health eSource
FDA Proposes Giving Clinical Research Sponsors More Input Prior to IDE Submissions
[10/02/13]
Off-Label Use of Medical Products: Warranty and Indemnification Considerations in Purchase Agreements
[04/11/13]
FTC Issues Mobile Privacy and Security Publications
[02/22/13]
Security Considerations in Technology Contracting - Implementing Information Security in Healthcare: Building a Security Program, HIMSS
HHS to Extend the Comment Period for Proposed Rulemaking on Human Subjects Research Protections
[08/31/11]
NLRB Issues Final Rule Requiring Private Employers to Post Notice of Employee Rights
[08/29/11]
HHS Issues Final Rule Updating Financial Conflict of Interest Rules for Investigators
[08/29/11]
Scientific Misconduct in Research - Journal of Health & Life Sciences Law, AHLA
We Know Where You Are: RFID In Healthcare - ABA Health eSource
Hospital Surge Capacity - AHLA
Resources
Webinars
Presentations
Articles and Webinars
Sign up to receive health care industry news.